Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Therapy01:28

Drug Therapy

32
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
32
Stress Prevention and Stress Management Techniques VI01:30

Stress Prevention and Stress Management Techniques VI

23
Adopting a healthier lifestyle often requires overcoming significant challenges, but leveraging psychological, social, and cultural resources can facilitate meaningful change. Effective self-change hinges on understanding and applying key tools such as motivation and goal setting, which help sustain efforts toward long-term health benefits.
Motivation and Self-Determination
Motivation, the driving force behind behavior, plays a pivotal role at every stage of the change process. The research...
23
Community Based Intervention01:30

Community Based Intervention

26
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
26
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry01:20

Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry

158
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
158
Factors Influencing Drug Absorption: Pharmaceutical Parameters01:28

Factors Influencing Drug Absorption: Pharmaceutical Parameters

104
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
104
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

97
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
97

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Use of Generative Artificial Intelligence in Systematic Literature Reviews: A Rapid Review of the Literature.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same author

Domains in Health Technology Assessment of Digital Health Technologies: A Mapping Review.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same author

Orticochea Flap for Reconstruction of Large Scalp Defects: Outcomes and Technique.

The Laryngoscope·2026
Same author

Financial Comparison of Single- vs 2-Stage Management of Bile Duct Stones.

JAMA surgery·2026
Same author

Understanding what motivates job choices among registered nurses: A discrete choice experiment study.

Nursing outlook·2026
Same author

Real-World Health Care Resource Utilization and Economic Burden Among Patients with Idiopathic Pulmonary Fibrosis in Commercially Insured and Medicare Advantage Populations in the United States.

Journal of health economics and outcomes research·2026

Related Experiment Video

Updated: May 15, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.2K

Stakeholders' Perspectives on Medication Adherence Enhancing Interventions.

Bijan J Borah1, Lisa J Pieretti2, Alan J Balch3

  • 1Mayo Clinic College of Medicine and Science and the Kern Center for the Science of Health Care Delivery, Rochester, MN, USA.

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|May 8, 2025
PubMed
Summary

Medication nonadherence affects 50% of patients, leading to adverse events and high costs. A systematic literature review found that while clinical outcomes are measured, economic and patient-reported outcomes need more focus for adherence interventions.

Keywords:
medication adherencestakeholder engagement

More Related Videos

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

12.8K
Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

13.4K

Related Experiment Videos

Last Updated: May 15, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.2K
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

12.8K
Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

13.4K

Area of Science:

  • Health Economics
  • Patient Adherence Research
  • Healthcare Management

Background:

  • Medication nonadherence presents a significant healthcare challenge with approximately 50% prevalence, leading to avoidable adverse events and substantial annual costs per person.
  • The ISPOR Medication Adherence and Persistence Special Interest Group's 2023 systematic literature review (SLR) aimed to evaluate measures for assessing medication adherence enhancing interventions (MAEIs).

Purpose of the Study:

  • To supplement SLR findings by presenting stakeholder perspectives on assessing MAEIs.
  • To identify gaps in outcome measurement for MAEIs and propose future research directions.

Main Methods:

  • Systematic literature review (SLR) conducted in 2023.
  • Analysis of stakeholder perspectives (patients, manufacturers, providers, health technology assessment agencies, payers).

Main Results:

  • The SLR revealed frequent measurement of medication adherence and clinical outcomes, but underexplored economic and patient-reported outcomes.
  • Stakeholders emphasize the need for MAEIs to demonstrate improved clinical outcomes, quality of life, and cost savings.
  • The SLR highlighted a need for consensus-based criteria for assessing MAEIs.

Conclusions:

  • MAEIs require a comprehensive approach, incorporating personalized strategies based on socioeconomic factors and social needs.
  • Future research should quantify MAEI implementation costs and stakeholder cost-bearing mechanisms for widespread adoption.
  • Integrating artificial intelligence and patient-centered approaches is crucial for developing effective, personalized adherence strategies.